Search results for "Dizziness"
New report proposes solutions to drug shortages
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/01/new-report-proposes-solutions-to-drug-shortages.htm
1 Jan 2020
Crossed Words: Finding alternatives
ACP Internist's puzzle feature challenges readers to find clues placed horizontally in rows to reveal an answer written vertically.
https://immattersacp.org/archives/2014/03/puzzle.htm
1 Mar 2014
Ranitidine pulled from market; COVID-19 updates
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/06/ranitidine-pulled-from-market-covid-19-updates.htm
1 Jun 2020
FDA updates boxed warnings for rosiglitazone, other drugs
The latest drug alerts and approvals.
https://immattersacp.org/archives/2008/01/fda.htm
1 Jan 2008
Start with bloodwork to diagnose anemia
Anemia is fairly common, but its many etiologies complicate diagnosis. It affects more than one in five black and Hispanic people, one in 10 seniors and one in five of those over the age of 85. Learn how to fine-tune the diagnosis to best help patients.
https://immattersacp.org/archives/2013/03/anemia.htm
1 Mar 2013
Warnings issued for antiepileptics, bowel prep, efalizumab
A summary of approvals, recalls, warnings and alerts.
https://immattersacp.org/archives/2009/02/fda.htm
1 Feb 2009
New warning for testosterone, approval for inhaled insulin
This update covers a revised warning on testosterone products about the risk of venous thromboembolism, and approval of a fast-acting inhaled insulin to treat diabetes in adults.
https://immattersacp.org/archives/2014/09/fda.htm
1 Sep 2014
Warnings on power cords, asthma drugs, diabetes supplies
A summary of approvals, recalls, warnings and alerts digested by ACP Internist from the Food and Drug Administration's alerts.
https://immattersacp.org/archives/2009/11/fda.htm
1 Nov 2009
Digoxin, Biosite Triage Cardiac Panel, insulin pumps recalled
A summary of approvals, recalls, warnings and alerts digested by ACP Internist from the Food and Drug Administration's alerts.
https://immattersacp.org/archives/2009/07/fda.htm
1 Jul 2009
New drugs approved for type 2 diabetes and COPD
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014